On April 12, 2024, Clover Biopharmaceuticals, Ltd closed the transaction. The transaction included participation from 10 investors, which includes a single non-accredited investor.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.335 HKD | +1.52% | -1.47% | -45.97% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.97% | 54.81M | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.98B | |
-24.33% | 19.27B | |
-19.35% | 15.99B | |
-17.95% | 15.66B | |
-48.32% | 14.5B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding